Patient Portals: A Platform for Connecting Communities of Care

Healthcare providers must adopt a strategic community perspective to drive true patient engagement, more efficient operations, improved care delivery and better clinical outcomes for their patients.
OTHER WHITEPAPERS
news image

Total Care Relative Resource Value (TCRRVTM)

whitePaper |

HealthPartners developed Total Care Relative Resource Values (TCRRVs) in 2004, as part of its Total Cost of Care measurement method. TCRRVs quantify resource-use for all procedures and services in a health care system, and are designed to facilitate easy comparisons within and across procedures, peer groups, and care settings (i.e. inpatient, outpatient, professional, and pharmacy). They are commonly used to support affordability initiatives, to identify instances of overuse / inefficiency, and to measure price variations.

Read More
news image

Framework for Demonstrating the Value of Medical Innovation

whitePaper | June 5, 2019

BioNJ, the life sciences trade association for New Jersey, is delighted to release the white paper, A Framework for Demonstrating the Value of Medical Innovation.” This white paper came to fruition as a result of BioNJ’s Beyond Value Frameworks: Defining the Value of Medical Innovation workshops. With nearly 3,300 life sciences establishments, including 12 of the world’s largest biopharmaceutical companies, having a headquarters or significant presence in the Garden State, New Jersey’s life sciences ecosystem was responsible for more than 40% of all new novel FDA drug approvals over the last two years – more than anyplace else in the world. It is crucial for patients to have access to this life-changing medical innovation. However, under current benefit designs, patients often don’t have access to the right medicines at the right time. The current paradigm frequently assumes a “one size fits all approach. As a result, innovator companies need to provide more information and insights to overcome these barriers to access. This white paper, authored by Shailja Dixit, M.D., M.S., M.P.H., President & Founder, ApexBio and Robert Goldberg, Ph.D., Vice President & Founder, Center for Medicine in the Public Interest, outlines a framework for assessing the true value of the innovation and identifies steps that innovator companies can take to demonstrate Differential Value of their innovation.

Read More
news image

Public Health

whitePaper | March 3, 2018

The focus of public health practitioners has shifted away from 20th century infectious diseases, which generally have been controlled, toward chronic diseases, which now account for seven out of every ten deaths in the United States.4 Land use and transportation planning and policy decisions can influence public health outcomes related to a variety of factors, such as air quality, opportunities for physical activity, risk of injury, jobs, education, and access to everyday necessities such as grocery stores.

Read More
news image

Community Health Needs Assessment

whitePaper | July 30, 2013

In continuation of our commitment to the health and well-being of our community members, Emory Healthcare and Emory University Hospital are pleased to present this Community Health Needs Assessment. This report assesses the needs of the community served by Emory University Hospital using quantitative data and input from individuals representing the broad interest of the community.

Read More
news image

Improving healthcare, reducing costs & saving lives

whitePaper | August 11, 2018

CuraToken CTKN is an EIP 20 Ethereum based utlity token which can be used to access medical adherence data via Curaizon’s CuraData platorm. This data is of interest to research insttutons, natonal health services and biotech companies. Blockchain technology will be used to store the patent permissions and ensure transparency and anonymity.

Read More
news image

Excellence in Medical Affair

whitePaper | February 1, 2017

As the roles of Medical Affairs have become more and more important, the China Medical Affairs Network CMAN conducted a survey in 2016 with the purpose of understanding the current state of Medical Affairs in pharmaceutical companies in China. A total number of 14 MNC pharmaceutical companies in China participated in this survey.

Read More